Ivy Rx vs Push Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Ivy Rx
Best for mainstream telehealth GLP-1 accessStarting at $175/mo
Push Health
Best for brand-name GLP-1 distribution via large pharmacy network (pending verification)Starting at $950/mo
Side-by-Side Comparison
| Feature | Ivy Rx | Push Health |
|---|---|---|
| Overall Score | ✓7.4/10 | 7.1/10 |
| Starting Price | ✓$175/mo | $950/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.6 ★ /5 |
| Features | 3 features | ✓5 features |
| States Available | ✓50 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Ivy Rx
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Push Health
Pros
- ✓Brand-name-only GLP-1 distribution (Ozempic, Zepbound, Mounjaro)
- ✓55,000+ pharmacy network per competitor sources
- ✓LegitScript certified per competitor sources
- ✓Listed in both competitor directories
Cons
- ✗Brand-name-only — no compounded option
- ✗Stub entry — exact pricing, insurance coordination, and clinician workflow need YMYL verification
- ✗Confidence LOW until verified
Our Verdict
Ivy Rx edges out Push Health with a higher overall score of 7.4/10 and is particularly strong for mainstream telehealth GLP-1 access. Push Health remains a solid alternative, especially if you're looking for brand-name GLP-1 distribution via large pharmacy network (pending verification).
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.